Targeting LRRK2 mutations in Parkinson's disease

被引：1
|
作者：
Lesniak, Robert K. [1 ,2 ]
Nichols, Robert Jeremy [2 ]
Smith, Mark [1 ]
Montine, Thomas J. [2 ]
机构：
[1] Stanford Univ, Sarafan ChEM H, Med Chem Knowledge Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA
来源：
FUTURE MEDICINAL CHEMISTRY | 2022年 / 14卷 / 16期
关键词：
computational chemistry and molecular modeling; drug design; drug discovery; inflammation therapeutics; neurological therapeutics; pharmacokinetics; pharmacodynamics; rare diseases; IDENTIFICATION; METAANALYSIS; DISCOVERY; DESIGN;
D O I：
10.4155/fmc-2022-0102
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1167 / 1170
页数：4
相关论文
共 50 条
  • [31] Function of LRRK2 in Parkinson's Disease
    Zhu Fei-Zhou
    Xia Kun
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (10) : 1059 - 1066
  • [32] LRRK2 pathobiology in Parkinson's disease
    Martin, Ian
    Kim, Jungwoo Wren
    Dawson, Valina L.
    Dawson, Ted M.
    JOURNAL OF NEUROCHEMISTRY, 2014, 131 (05) : 554 - 565
  • [33] LRRK2 and Proteostasis in Parkinson's Disease
    Perez-Carrion, Maria Dolores
    Posadas, Inmaculada
    Solera, Javier
    Cena, Valentin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [34] LRRK2 and idiopathic Parkinson's disease
    Rocha, Emily M.
    Keeney, Matthew T.
    Di Maio, Roberto
    De Miranda, Briana R.
    Greenamyre, J. Timothy
    TRENDS IN NEUROSCIENCES, 2022, 45 (03) : 224 - 236
  • [35] Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations
    Macias-Garcia, Daniel
    Perinan, Maria Teresa
    Munoz-Delgado, Laura
    Jesus, Silvia
    Jimenez-Jaraba, Maria Valle
    Buiza-Rueda, Dolores
    Bonilla-Toribio, Marta
    Adarmes-Gomez, Astrid
    Carrillo, Fatima
    Gomez-Garre, Pilar
    Mir, Pablo
    MOVEMENT DISORDERS, 2022, 37 (01) : 225 - 227
  • [36] Molecular biology changes associated with LRRK2 mutations in Parkinson's disease
    Lu, Yi Wei
    Tan, Eng-King
    JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (09) : 1895 - 1901
  • [37] LRRK2 and GBA Founder Mutations and their Interactions in Parkinson's disease (PD)
    Kmiecik, M.
    Riboldi, G.
    Schneider, R.
    Stagaman, K.
    Sonmez, T. Filshtein
    Guan, A.
    Wetzel, M.
    Fontanillas, P.
    Holmes, M.
    Aslibekyan, S.
    Norcliffe-Kaufmann, L.
    MOVEMENT DISORDERS, 2024, 39 : S761 - S761
  • [38] Alpha-synuclein oligomers in Parkinson's disease with LRRK2 mutations
    Sekiya, H.
    Hashimoto, Y.
    Takata, M.
    Koga, S.
    Hasegawa, K.
    Kowa, H.
    Toda, T.
    Wszolek, Z.
    Dickson, D.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 514 - 514
  • [39] Identification of novel mutations in LRRK2 gene in patients with Parkinson's disease
    Jankovic, M.
    Kresojevic, N. D.
    Dobricic, V.
    Markovic, V.
    Petrovic, I.
    Novakovic, I.
    Kostic, V. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 354 - 354
  • [40] Association Between Cancer and LRRK2 Mutations in Parkinson's Disease Patients
    Inzelberg, R.
    Hassin-Baer, S.
    Cohen, O. S.
    Aharon-Peretz, J.
    Schlesinger, I.
    Gershoni, R.
    Djaldetti, R.
    Schechtman, E.
    Friedman, E.
    MOVEMENT DISORDERS, 2010, 25 : S648 - S649
12345